Patheon Says JV Partner Can’t Sue Over $255M Acquisition

Law360, New York (January 15, 2013, 7:56 PM EST) -- Patheon Inc. on Monday urged a Florida federal court to toss a challenge to the company's $255 million acquisition of a pharmaceutical company, saying joint venture partner Procaps SA, which had lodged the antitrust suit, would benefit from the deal's alleged anti-competitive impacts.

Patheon, a company that provides manufacturing and contract development services in the pharmaceutical industry, told the court it should dismiss the challenge to its acquisition of Banner Pharmacaps Europe BV, arguing that Procaps lacked standing because it actually stood to benefit from the...
To view the full article, register now.